s an important step in our growth strategy. It allows our EU distribution partners to build on the initial launch of Avance® Nerve Graft in Europe and bring the rest of our portfolio of nerve repair products to surgeons and patients. Similar to the experience in the US, we believe these products will be well received to treat a wide variety of peripheral nerve injuries from simple lacerations of the finger to complex extremity reconstructions.”
About AxoGen, Inc.
AxoGen (AXGN) is a regenerative medicine company dedicated to advancing the science and commercialization of peripheral nerve repair solutions. The Company’s innovative approach to regenerative medicine has resulted in first-in-class products that will define their product categories. AxoGen’s products offer a full suite of surgical nerve reconstruction solutions including Avance® Nerve Graft, the only commercially available processed nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa ECM coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce coaptation sites while preventing soft tissue attachments. For more information, visit our website at http://www.axogeninc.com.
AxoGuard® Nerve Connector and AxoGuard® Nerve Protector are manufactured in the United States by Cook Biotech Incorporated, West Lafayette, Indiana, and are distributed exclusively by AxoGen.
AxoGen is the parent of its wholly owned operating subsidiary, AxoGen Corporation. AxoGen’s principal executive office and operations are located in Alachua, FL.
Cautionary Statements Concerning Forward-Looking Statements
This Press Release contains “forward-looking” statement
Page: 1 2 3 Related medicine news :1
Copyright©2012 Vocus, Inc.
All rights reserved
. AxoGen, Inc. to sponsor Educational Symposium and Panel Discussion at 2013 Annual Meetings of American Association for Hand Surgery, American Society for Peripheral Nerve, and American Society for Reconstructive Microsurgery2
. AxoGen, Inc. Announces Presentation of Avance® Nerve Graft Data at American Association for Hand Surgery 2013 Annual Meeting3
. AxoGen, Inc. Announces Presentation of Avance® Nerve Graft Data at American Society for Peripheral Nerve & American Society for Reconstructive Microsurgery 2013 Meetings4
. AxoGen, Inc. Appoints Shawn McCarrey as Vice President of Sales5
. AxoGen, Inc. to Highlight Products at the American Academy of Orthopedic Surgeons 2013 Meeting6
. AxoGen, Inc. Announces Release Date of First Quarter 2013 Results and Conference Call7
. AFAR announces the 2012 Hartford Centers of Excellence in Geriatric Medicine awards8
. Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder9
. University of Houston Graduate College of Social Work announces partnership with MD Anderson10
. The Ludwig Institute for Cancer Research announces launch of iTeos Therapeutics SA11
. AGA announces prestigious awards recognition recipients